Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2019 Oct 16;160(1):132–139.e1. doi: 10.1016/j.jtcvs.2019.09.151

Table 3:

Post-operative Patient Outcomes

Group 1(HM3)
(n=19)
Group 2
(n=85)
p-value
30 Day Mortality 0 (0%) 9 (10.6%) 0.21
90 Day Mortality 0 (0%) 15 (17.6%) 0.07
Dialysis Post-op 1 (5.3%) 16 (18.8%) 0.19
RV Dysfunction Post-op 0.47
 None 2 (10.5%) 14 (16.5%)
 Mild 3 (15.8%) 23 (27.1%)
 Moderate 8 (42.1%) 33 (38.8%)
 Severe 6 (31.6%) 15 (17.6%)
Hospital LOSa
 Median [Min, Max] 24.0 [12.0, 226] 27.0 [7.00, 165 0.51
ICU LOSq
 Median [Min, Max] 7.00 [3.00, 223] 13.5 [2.00, 165] 0.32
Number of Readmissions per 365 Days of VAD Support
 Median [Min, Max] 1.85 [0.00, 12.4] 2.03 [0.00, 23.4] 0.28
NYHA Postop 0.67
 NYHA I 2 (10.5%) 16 (18.8%)
 NYHA II 10 (52.6%) 33 (38.8%)
 NYHA III 4 (26.3%) 15 (17.6%)
 NYHA IV 1 (10.5%) 4 (4.7%)
Missing 0 (0%) 17 (20%)

LOS, length of stay; RV, right ventricular; NYHA, New York Heart Association; ICU, intensive care unit; VAD, ventricular assist device;

a

days